While there is evidence of significant depletion of CD4 T cells in COVID-19 patients [272] and CD4 cell deficiency is the most important driving factor for the development of PCP, as seen in AIDS, the incidence of PCP in COVID-19 appears to be far lower than that reported in AIDS. Here, CD4 is linked to COVID-19.